68Ga-DOTA-IBA Uptake in Meningioma and Liver Metastasis of Breast Cancer
A 41-year-old woman with bone and liver metastasis of breast cancer was enrolled in our 68 Ga-labeled DOTA-ibandronic acid ( 68 Ga-DOTA-IBA) PET/CT tumor clinical trial. The examination revealed increased uptake of 68 Ga-DOTA-IBA in the multiple bone metastases. Unexpectedly, 68 Ga-DOTA-IBA uptake in meningioma and liver metastasis were also noted.
Authors
- Jiqing Xuan
- Lin Chen (ORCID: https://orcid.org/0000-0003-0108-4309)
- Yue Chen (ORCID: https://orcid.org/0000-0003-4088-7649)
- Juan Liang (ORCID: https://orcid.org/0000-0002-8884-4675)
- Haoyuan Ding
Institutions
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1097/rlu.0000000000005890
- Citations
- 1
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 1.36